In this study, we identified three drugs cytotoxic to RRP cells and all of them have IC 50s that are within the safe range of therapeutic use and covering different classes of drugs such as CDK inhibitors, HDAC inhibitors, and non cancer drugs such as Forskolin. The gene discussed is HDAC9; the disease is cancer.